Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Bloom

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Pharmacology|September 25, 2013
Gut hormones as therapeutic agents in treatment of diabetes and obesityTricia Tan, Stephen Bloom
Vitamins and Hormones|February 5, 2013
Gut hormones and obesity: physiology and therapiesRebecca Scott, Tricia Tan, Stephen Bloom
Expert Opinion on Drug Discovery|July 30, 2019
Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 yearsFrances Rose, Stephen Bloom, Tricia Tan
Trends in Pharmacological Sciences|December 7, 2010
Emerging therapies in the treatment of 'diabesity': beyond GLP-1George Tharakan, Tricia Tan, Stephen Bloom
Expert Review of Clinical Pharmacology|March 12, 2013
Treating the obese diabeticJulia Kenkre, Tricia Tan, Stephen Bloom
The Proceedings of the Nutrition Society|May 3, 2008
Gut hormones and the treatment of disease cachexiaDamien Ashby, Peter Choi, Stephen Bloom
BMJ (Clinical Research Ed.)|June 21, 2003
A career in metabolic medicineTahseen A Chowdhury, Stephen Bloom, Robert Cramb
Physiological Reviews|September 27, 2005
Hormonal regulation of food intakeSarah Stanley, Katie Wynne, Barbara McGowan, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2023
Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis BSteven Trinh, Bridgette Andrew, Stephen Bloom, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 22, 2019
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltoseWendy Fang, Lawrence P McMahon, Stephen Bloom, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Pharmacology|September 25, 2013
Gut hormones as therapeutic agents in treatment of diabetes and obesityTricia Tan, Stephen Bloom
Vitamins and Hormones|February 5, 2013
Gut hormones and obesity: physiology and therapiesRebecca Scott, Tricia Tan, Stephen Bloom
Expert Opinion on Drug Discovery|July 30, 2019
Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 yearsFrances Rose, Stephen Bloom, Tricia Tan
Trends in Pharmacological Sciences|December 7, 2010
Emerging therapies in the treatment of 'diabesity': beyond GLP-1George Tharakan, Tricia Tan, Stephen Bloom
Expert Review of Clinical Pharmacology|March 12, 2013
Treating the obese diabeticJulia Kenkre, Tricia Tan, Stephen Bloom
The Proceedings of the Nutrition Society|May 3, 2008
Gut hormones and the treatment of disease cachexiaDamien Ashby, Peter Choi, Stephen Bloom
BMJ (Clinical Research Ed.)|June 21, 2003
A career in metabolic medicineTahseen A Chowdhury, Stephen Bloom, Robert Cramb
Physiological Reviews|September 27, 2005
Hormonal regulation of food intakeSarah Stanley, Katie Wynne, Barbara McGowan, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2023
Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis BSteven Trinh, Bridgette Andrew, Stephen Bloom, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 22, 2019
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltoseWendy Fang, Lawrence P McMahon, Stephen Bloom, et al.
Pageof 5